openPR Logo
Press release

Antihypertensive Drugs Market Report 2021-2031 : Newly Published By Visiongain.

04-01-2021 10:06 AM CET | Health & Medicine

Press release from: Visiongain Ltd

Antihypertensive Drugs Market Report 2021-2031 : Newly

Forecasts By Drug (Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers and Others), By Condition (Primary Hypertension and Secondary Hypertension), By Medication type (Monotherapy, Combination Therapy and Fixed Dose Combinations), By Drug Type (Generic Drugs and Branded Drugs), By Patient Demographics (Geriatric Patient, Adult Patient and Pediatric), By End-User (Hospitals, Homecare, Specialty Clinics and Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy, Ecommerce and Others), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios

Purchase the full report or download free sample pages: https://www.visiongain.com/report/antihypertensive-drugs-market-2021/

Discover sales predictions for the world market and submarkets

Revenue and growth forecasts from 2021 to 2031 for the Global Antihypertensive Drugs Market By Drug
• Diuretics
o Thiazide Diuretics
o Loop Diuretics
o Potassium-sparing Diuretics
• Angiotensin Converting Enzyme Inhibitors
• Angiotensin Receptor Blockers
• Beta-blockers
o Beta-1 Selective
o Intrinsic Sympathomimetic
• Vasodilators
• Calcium Channel Blockers
• Renin Inhibitors
• Alpha-blockers
• Others

Revenue and growth forecasts from 2021 to 2031 for the Global Antihypertensive Drugs Market By Condition
• Primary Hypertension
• Secondary Hypertension

Revenue and growth forecasts from 2021 to 2031 for the Global Antihypertensive Drugs Market By Medication Type
• Monotherapy
• Combination Therapy
• Fixed Dose Combinations

Revenue and growth forecasts from 2021 to 2031 for the Global Antihypertensive Drugs Market By Drug Type
• Generic Drugs
• Branded Drugs

Revenue and growth forecasts from 2021 to 2031 for the Global Antihypertensive Drugs Market By Patient Demographics
• Geriatric Patient
• Adult Patient
• Pediatric

Revenue and growth forecasts from 2021 to 2031 for the Global Antihypertensive Drugs Market By End-User
• Hospitals
• Homecare
• Specialty Clinics
• Others

Revenue and growth forecasts from 2021 to 2031 for the Global Antihypertensive Drugs Market by Distribution Channel
• Hospital Pharmacy
• Retail pharmacy
• Ecommerce
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa

The report also includes profiles and for some of the leading companies in the Antihypertensive Drugs Market, with a focus on this segment of these companies’ operations.

Find more research reports on pharmaceutical Industry, by Visiongain:
• Biological Imaging Reagents Market Report 2021-2031 : https://www.visiongain.com/report/biological-imaging-reagents-market-2021/

•Antihypertensive Drugs Market Report 2021-2031 : https://www.visiongain.com/report/antihypertensive-drugs-market-2021/

•Cholesterol Lowering Drugs Market Report 2021-2031 : https://www.visiongain.com/report/cholesterol-lowering-drugs-report-2021/

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Contact:
Sara Peerun
Commercial Director
Visiongain Limited
Phone: +44 (0) 20 7549 9987.
Email: sara.peerun@visiongain.com
Web: https://www.visiongain.com/
Address : Airport House, Purley Way Surrey, London
CR0 0XZ

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent market research and consulting company in Europe. Based in London, UK, the company comprises over 400+ analysts and consultants, adding more than 1400 market research reports to its vast database each year. These reports offer in-depth analysis on 18 industries worldwide. With the help of an interactive market intelligence platform, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

SOURCE Visiongain Ltd.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antihypertensive Drugs Market Report 2021-2031 : Newly Published By Visiongain. here

News-ID: 2264664 • Views:

More Releases from Visiongain Ltd

Animal Model Market Report Up to 2031
Animal Model Market Report Up to 2031
Visiongain has published a new report on Animal Model Market Report to 2031: Forecasts by Animal Type (Mice, Rats, Fish, Birds, Cattle, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies
Bakery Ingredients Market Report Up to 2031
Bakery Ingredients Market Report Up to 2031
Visiongain has published a new report on Bakery Ingredients Market Report to 2031: Forecasts by Ingredient Type (Enzymes, Emulsifiers, Leavening Agents, Oils, Fats, and Shortenings, Baking Powder & Mixes, Colors & Flavors, Fiber, Starch, Antimicrobials, Preservatives, Others), By Application (Cakes & Pastries, Bread, Rolls And Pies, Cookies & Biscuits, Others ), By Distribution Channel (B2B, B2C (Online Channels, Offline Channels) PLUS Profiles of Leading Bakery Ingredients Manufacturing Companies and Regional
Artificial Meat Market Report Up to 2031
Artificial Meat Market Report Up to 2031
Visiongain has published a new report on Artificial Meat Market Report to 2031: Forecasts by Product Type (Beef, Seafood, Pork, Poultry, Duck), By Application (Sausages, Meatballs, Burgers, Nuggets, Hot dogs), By Distribution Channel (B2B, B2C (Online Channels, Offline Channels) PLUS Profiles of Leading Artificial Meat Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/artificial-meat-market/#download_sampe_div Rising consumption of animal based-products and industrialization
Aquafeed Market Research Report Up to 2031
Aquafeed Market Research Report Up to 2031
Visiongain has published a new report on Aquafeed Market Report to 2031: Forecasts By Ingredient (Soybean, Corn, Fish Meal, Additives, Fish Oil, Others), By Additives (Vitamins & Minerals, Prebiotics & Probiotics, Amino Acids, Antibiotics, Enzymes, Antioxidants, Others), By Species (Fish, Crustaceans, Mollusks, Others), By Form (Dry, Moist, Wet), By Lifecycle (Grower Feed, Finisher Feed, Starter Feed, Brooder Feed), By Distribution Channel (Online Channels, Offline Channels) PLUS Profiles of Leading Aquafeed

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug